These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19137)

  • 21. Biochemical and clinical effects of ethane-1-hydroxy-1,1-diphosphonate in calcium nephrolithiasis.
    Baumann JM; Bisaz S; Fleisch H; Wacker M
    Clin Sci Mol Med; 1978 May; 54(5):509-16. PubMed ID: 108043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of urine pretreatment on calcium oxalate crystallization inhibition potentials.
    White DJ; Christoffersen J; Herman TS; Lanzalaco AC; Nancollas GH
    J Urol; 1983 Jan; 129(1):175-9. PubMed ID: 6827679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formation of hydrated calcium oxalates in the presence of poly-L-aspartic acid.
    Wesson JA; Worcester E
    Scanning Microsc; 1996; 10(2):415-23; 423-4. PubMed ID: 9813620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of calcium oxalate monohydrate (COM) crystal growth by pyrophosphate, citrate and rat urine.
    Sidhu H; Gupta R; Thind SK; Nath R
    Urol Res; 1986; 14(6):299-303. PubMed ID: 3027939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the organic matter in calcium oxalate lithiasis.
    Grases F; Isern B; Perello J; Costa-Bauza A
    Front Biosci; 2005 May; 10():1534-8. PubMed ID: 15769643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnesium, citrate, magnesium citrate and magnesium-alkali citrate as modulators of calcium oxalate crystallization in urine: observations in patients with recurrent idiopathic calcium urolithiasis.
    Schwille PO; Schmiedl A; Herrmann U; Fan J; Gottlieb D; Manoharan M; Wipplinger J
    Urol Res; 1999 Apr; 27(2):117-26. PubMed ID: 10424393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth of calcium oxalate crystals. II. Inhibition by natural urinary crystal growth inhibitors.
    Meyer JL; Smith LH
    Invest Urol; 1975 Jul; 13(1):36-9. PubMed ID: 166960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An ATR-FTIR study of different phosphonic acids in aqueous solution.
    Zenobi MC; Luengo CV; Avena MJ; Rueda EH
    Spectrochim Acta A Mol Biomol Spectrosc; 2008 Jul; 70(2):270-6. PubMed ID: 17826311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The direct measurement of inhibitory capacity to crystal growth of calcium oxalate in undiluted urine and in other inhibitor containing solutions.
    Baumann JM; Wacker M
    Urol Res; 1980; 8(3):171-5. PubMed ID: 6252673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Growth of calcium oxalate crystals in vitro: a simple method for measurement of the inhibitory action of human urine (author's transl)].
    Hess B; Binswanger U
    J Clin Chem Clin Biochem; 1981 May; 19(5):295-9. PubMed ID: 7264571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tamm-Horsfall mucoproteins promote calcium oxalate crystal formation in urine: quantitative studies.
    Rose GA; Sulaiman S
    J Urol; 1982 Jan; 127(1):177-9. PubMed ID: 7057493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins.
    Hess B; Nakagawa Y; Coe FL
    Am J Physiol; 1989 Jul; 257(1 Pt 2):F99-106. PubMed ID: 2750929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro effect of lemon and orange juices on calcium oxalate crystallization.
    Kulaksizoğlu S; Sofikerim M; Cevik C
    Int Urol Nephrol; 2008; 40(3):589-94. PubMed ID: 17721827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory activity of whole urine: a comparison of urines from stone formers and healthy subjects.
    Ryall RL; Hibberd CM; Mazzachi BC; Marshall VR
    Clin Chim Acta; 1986 Jan; 154(1):59-67. PubMed ID: 3943225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A method for studying inhibitory activity in whole urine.
    Ryall RL; Hibberd CM; Marshall VR
    Urol Res; 1985; 13(6):285-9. PubMed ID: 3006313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcium oxalate crystallization kinetics at different concentrations of human and artificial urine, with a constant calcium to oxalate ratio.
    Kavanagh JP; Jones L; Rao PN
    Urol Res; 1999 Aug; 27(4):231-7. PubMed ID: 10460891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcium oxalate crystallization in undiluted postprandial urine of healthy male volunteers as influenced by citrate.
    Fan J; Schwille PO; Schmiedl A; Fink E; Manoharan M
    Arzneimittelforschung; 2001 Oct; 51(10):848-57. PubMed ID: 11715639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory effects of urinary macromolecules on the crystallization of calcium oxalate.
    Gill WB; Karesh JW; Garsin L; Roma MJ
    Invest Urol; 1977 Sep; 15(2):95-9. PubMed ID: 903217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcium oxalate dihydrate crystal growth.
    Werness PG; Duckworth SC; Smith LH
    Invest Urol; 1979 Nov; 17(3):230-3. PubMed ID: 40922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Observations upon calcium oxalate crystallization kinetics in simulated urine.
    Miller JD; Randolph AD; Drach GW
    J Urol; 1977 Mar; 117(3):342-5. PubMed ID: 14266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.